Cardiovascular burden of individuals diagnosed with idiopathic hypersomnia: Real-World Idiopathic Hypersomnia Total Health Model (CV-RHYTHM)
Individuals with idiopathic hypersomnia had higher odds of prevalent cardiovascular conditions or events than matched controls. These results reinforce that clinicians should be aware of patients' cardiovascular risk profiles when selecting idiopathic hypersomnia treatments.
Authors
- Marisa Whalen
- D. Profant (ORCID: https://orcid.org/0000-0003-4323-9348)
- Prasheel Lillaney
- Weiyi Ni (ORCID: https://orcid.org/0000-0003-4244-0699)
- Elizabeth M. Poole (ORCID: https://orcid.org/0000-0002-4680-4587)
- Douglas S. Fuller (ORCID: https://orcid.org/0000-0002-2448-5896)
- Trevor Alvord (ORCID: https://orcid.org/0009-0005-9428-4060)
- Patricia Prince (ORCID: https://orcid.org/0000-0002-0705-6942)
- Ragy Saad
- Jed E. Black (ORCID: https://orcid.org/0000-0002-2812-2435)
- Shaina Desai (ORCID: https://orcid.org/0000-0003-2497-4777)
Institutions
- Jazz Pharmaceuticals (United States) (US)
- Aetion (United States) (US)
- Jazz Pharmaceuticals (Italy) (IT)
Publication Details
- Journal
- Sleep Medicine
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1016/j.sleep.2025.106587
- Citations
- 1
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Jazz Pharmaceuticals